InnovAge Holding Corp. Lease, Cost
InnovAge Holding Corp. (INNV) reported Lease, Cost of $12.84 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-09-09
- InnovAge Holding Corp. lease, cost for the quarter ending 2026-06-30 was $3.78M, a 49.29% decline year-over-year.
- InnovAge Holding Corp. lease, cost for the quarter ending 2026-03-31 was $2.94M, a 104.66% increase year-over-year.
- InnovAge Holding Corp. lease, cost for the quarter ending 2025-12-31 was $2.98M, a 125.45% increase year-over-year.
- InnovAge Holding Corp. lease, cost for the quarter ending 2025-09-30 was $3.14M, a 7.54% increase year-over-year.
- InnovAge Holding Corp. lease, cost for fiscal 2026 was $12.84M, a 2.22% decline from fiscal 2025.
- InnovAge Holding Corp. lease, cost for fiscal 2025 was $13.13M, a 71.60% increase from fiscal 2024.
- InnovAge Holding Corp. lease, cost for fiscal 2024 was $7.65M, a 16.54% decline from fiscal 2023.
- InnovAge Holding Corp. lease, cost for fiscal 2023 was $9.17M.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $6.72M derived: sum of 2 quarters · filed 2026-09-09 | $9.70M derived: sum of 3 quarters · filed 2026-09-09 | $12.84M 10-K · filed 2026-09-09 |
| 2026-03-31 | $2.94M 10-Q · filed 2026-05-08 | $5.92M derived: sum of 2 quarters · filed 2026-05-08 | $9.06M 10-Q · filed 2026-05-08 | $16.51M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-12-31 | $2.98M 10-Q · filed 2026-02-03 | $6.11M 10-Q · filed 2026-02-03 | $13.57M derived: sum of 3 quarters · filed 2026-09-09 | $15.01M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-09-30 | $3.14M 10-Q · filed 2025-11-04 | $10.59M derived: sum of 2 quarters · filed 2026-09-09 | $12.03M derived: sum of 3 quarters · filed 2026-09-09 | $13.35M derived: sum of 4 quarters · filed 2026-09-09 |
| 2025-06-30 | $7.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09 | $8.89M derived: sum of 2 quarters · filed 2026-09-09 | $10.21M derived: sum of 3 quarters · filed 2026-09-09 | $13.13M 10-K · filed 2026-09-09 |
| 2025-03-31 | $1.44M 10-Q · filed 2026-05-08 | $2.76M derived: sum of 2 quarters · filed 2026-05-08 | $5.68M 10-Q · filed 2026-05-08 | $5.78M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.32M 10-Q · filed 2026-02-03 | $4.24M 10-Q · filed 2026-02-03 | $4.34M derived: sum of 3 quarters · filed 2026-02-03 | $7.06M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $2.92M 10-Q · filed 2025-11-04 | $3.02M derived: sum of 2 quarters · filed 2025-11-04 | $5.74M derived: sum of 3 quarters · filed 2025-11-04 | $8.28M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09 | $2.82M derived: sum of 2 quarters · filed 2025-09-09 | $5.36M derived: sum of 3 quarters · filed 2025-09-09 | $7.65M 10-K · filed 2025-09-09 |
| 2024-03-31 | $2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-06 | $5.25M derived: sum of 2 quarters · filed 2025-05-06 | $7.54M 10-Q · filed 2025-05-06 | $9.53M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-04 | $4.83M 10-Q · filed 2025-02-04 | $6.82M derived: sum of 3 quarters · filed 2025-02-04 | $9.18M derived: sum of 4 quarters · filed 2025-02-04 |
| 2023-09-30 | $2.29M 10-Q · filed 2024-11-05 | $4.28M derived: sum of 2 quarters · filed 2024-11-05 | $6.64M derived: sum of 3 quarters · filed 2024-11-05 | $9.34M derived: sum of 4 quarters · filed 2024-11-05 |
| 2023-06-30 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10 | $4.35M derived: sum of 2 quarters · filed 2024-09-10 | $7.04M derived: sum of 3 quarters · filed 2024-09-10 | $9.17M 10-K · filed 2024-09-10 |
| 2023-03-31 | $2.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | $5.06M derived: sum of 2 quarters · filed 2024-05-07 | $7.18M 10-Q · filed 2024-05-07 | |
| 2022-12-31 | $2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-06 | $4.82M 10-Q · filed 2024-02-06 | ||
| 2022-09-30 | $2.12M 10-Q · filed 2023-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |